FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2332073270> ?p ?o ?g. }

• W2332073270 abstract "Objective: Matrix metalloproteinase-3 (MMP-3) has been implicated in experimental and clinical models of human inflammatory conditions. Increased MMPs levels have been shown in serum and body fluids in inflammatory conditions. Familial Mediterranean Fever (FMF) is an inherited, auto inflammatory disease characterized by recurrent self-limited bouts of fever and localized inflammation. We aimed to investigate whether urine MMP-3 level can serve as a biomarker for monitoring attack in FMF patients in daily practice. Methods: We studied 50 patients diagnosed with FMF according to Tel Hashomer criteria and 32 age-matched healthy controls. We determined all subjects both in attack (FMF-AP) and attack free period (FMF-AFP) groups. Serum and urine samples were obtained within the first 6-24 h of the AP, and 10 days later after the attack (AFP). The serum samples were measured on the same day while urine samples were frozen immediately and stored at -80°C. Results: The mean age at onset was 57.26 ± 33.5 months. The most common symptoms seen during the attacks were: fever (80%) abdominal pain (72%), arthritis (40%). In genotype distribution, homozygous M694V mutation was seen mostly (28%). During AP, urine MMP-3 levels of patients were higher as well as during AFP and controls (2.32 ± 0.51, 0.89 ± 2.29 ng/mL and 1.24 ± 0.17 ng/mL, respectively, p=0.00). In AP, urinary MMP levels were higher in patients with arthritis than others (p<0.05). Urinary MMP-3 levels were also significantly higher in males (2.29 ± 0.45 versus 2.24 ± 0.57, p=0, 00). The patients with M694V allele (n=29) had statistically significant high urine MMP-3 levels than others (2.37 ± 0.56 versus 1.99 ± 0.31, p=0.04, respectively). Also, acute phase reactants were higher in patients with M694V allele without statistically significant difference (p=0.89, 0.75, 0.86, 0.85, 0.7, respectively). Conclusion: In this study we focused on presence of MMPs in urine and showed inflammation-specific MMP patterns may provide clinicians valuable information in FMF patients." @default.
• W2332073270 created "2016-06-24" @default.
• W2332073270 creator A5010382336 @default.
• W2332073270 date "2014-01-01" @default.
• W2332073270 modified "2023-10-18" @default.
• W2332073270 title "Urine Matrix Metalloproteinase-3 Level as a Biomarker for Monitoring in Familial Mediterranean Fever Attacks" @default.
• W2332073270 cites W1886431664 @default.
• W2332073270 cites W1971534684 @default.
• W2332073270 cites W1977807564 @default.
• W2332073270 cites W1980930513 @default.
• W2332073270 cites W2002511600 @default.
• W2332073270 cites W2036272657 @default.
• W2332073270 cites W2040953906 @default.
• W2332073270 cites W204492468 @default.
• W2332073270 cites W2049477443 @default.
• W2332073270 cites W2093521383 @default.
• W2332073270 cites W2109658199 @default.
• W2332073270 cites W2110922412 @default.
• W2332073270 cites W2112413460 @default.
• W2332073270 cites W2116670685 @default.
• W2332073270 cites W2122605756 @default.
• W2332073270 cites W2149769197 @default.
• W2332073270 cites W2342129036 @default.
• W2332073270 cites W2395493212 @default.
• W2332073270 cites W2419627917 @default.
• W2332073270 cites W1880966689 @default.
• W2332073270 doi "https://doi.org/10.4172/2161-0959.1000164" @default.
• W2332073270 hasPublicationYear "2014" @default.
• W2332073270 type Work @default.
• W2332073270 sameAs 2332073270 @default.
• W2332073270 citedByCount "0" @default.
• W2332073270 crossrefType "journal-article" @default.
• W2332073270 hasAuthorship W2332073270A5010382336 @default.
• W2332073270 hasBestOaLocation W23320732701 @default.
• W2332073270 hasConcept C109523444 @default.
• W2332073270 hasConcept C126322002 @default.
• W2332073270 hasConcept C142724271 @default.
• W2332073270 hasConcept C203014093 @default.
• W2332073270 hasConcept C2779134260 @default.
• W2332073270 hasConcept C2779537928 @default.
• W2332073270 hasConcept C2780026642 @default.
• W2332073270 hasConcept C2781197716 @default.
• W2332073270 hasConcept C2991819120 @default.
• W2332073270 hasConcept C54355233 @default.
• W2332073270 hasConcept C71924100 @default.
• W2332073270 hasConcept C86803240 @default.
• W2332073270 hasConceptScore W2332073270C109523444 @default.
• W2332073270 hasConceptScore W2332073270C126322002 @default.
• W2332073270 hasConceptScore W2332073270C142724271 @default.
• W2332073270 hasConceptScore W2332073270C203014093 @default.
• W2332073270 hasConceptScore W2332073270C2779134260 @default.
• W2332073270 hasConceptScore W2332073270C2779537928 @default.
• W2332073270 hasConceptScore W2332073270C2780026642 @default.
• W2332073270 hasConceptScore W2332073270C2781197716 @default.
• W2332073270 hasConceptScore W2332073270C2991819120 @default.
• W2332073270 hasConceptScore W2332073270C54355233 @default.
• W2332073270 hasConceptScore W2332073270C71924100 @default.
• W2332073270 hasConceptScore W2332073270C86803240 @default.
• W2332073270 hasIssue "03" @default.
• W2332073270 hasLocation W23320732701 @default.
• W2332073270 hasOpenAccess W2332073270 @default.
• W2332073270 hasPrimaryLocation W23320732701 @default.
• W2332073270 hasRelatedWork W2059599060 @default.
• W2332073270 hasRelatedWork W2183306761 @default.
• W2332073270 hasRelatedWork W2317627644 @default.
• W2332073270 hasRelatedWork W2342156317 @default.
• W2332073270 hasRelatedWork W2956592345 @default.
• W2332073270 hasRelatedWork W2969815213 @default.
• W2332073270 hasRelatedWork W3217418999 @default.
• W2332073270 hasRelatedWork W4231920340 @default.
• W2332073270 hasRelatedWork W4310714044 @default.
• W2332073270 hasRelatedWork W763232410 @default.
• W2332073270 hasVolume "04" @default.
• W2332073270 isParatext "false" @default.
• W2332073270 isRetracted "false" @default.
• W2332073270 magId "2332073270" @default.
• W2332073270 workType "article" @default.